Member Info for crumbs

https://www.keytruda.com/head-and-neck-cancer/keytruda-clinical-trials/

Quite a sobering read ....

As for beans to spill all I can say is IMHO backed by some research online this is a genuine modi 1 trial patient and person with a life that we all hope is extended and improved by modi 1 and that she is one of the first of millions

pff he drinks that Chang stuff

First DNA Immuno vaxs were approved for veterinary use... A lot of people care more for their pets than their fellow man!

I could also divulge more about my internet investigations (which anyone can d lol) but I will not... what I will say is .... could be one day in not too distant future that Modify patient stories hit the mainstream.... then what

I get the moral implications with this but....
https://community.macmillan.org.uk/cancer_types/head-neck-cancer-forum/f/updates/233631/immunotherapy-changes

No Lindy media yet why and when will it come.... BOD who is coming in?... What if or maybe even when the mainstream media start covering modi 1 patient stories .... When do if modi 1 is clearly working (and no that will not take the full complete trial ) scancell start to commercialise moditope and how ...modi 3 first maybe? Hello Sahin/Mellman...not to mention Covidity MaBs AvidiMab and who knows what with scancell but... at long last happy times may well be something we will have to acclimatise to lol... and loads more names on this BB :)

Remember something else... there can be many many moditopes and indeed moditope combinations...

Comparatively to other infact possibly all other biotechs is the money scancell has had invested in it is peanuts... the Redmile investment is compared to their usual ones tiny... yet the potential returns are possibly bigger than any one of their other investments... my thinking on this is... they will also not undervalue a working moditope...... far far from it

Yes, a great as usual Burble post one thing I will add is and it may also help answer the what if cancer tries to escape element of the question... there is a lot to the genius of what Lindy describes as the simplicity of moditope.... basically... those thrown up by cancer red flags that moditope educated the CD4 killer T cells respond to get thrown up even more when under that attack... yeah cancer hastens its own demise at least that is my understanding :)

Then CRUK dropping SCIB2 aghh though you never know iSCIB2 the missing piece from results may well be the next deal?

Yes still early days but what we have heard today adds so much literal life to the last RNS

Chester no doubt that is the thing about scancell they never if you like sleep they learn and improve as you would expect a team of great scientists to do.....

May have to pinch ourselves but could we finally be in for the era of pay off.... the reward for our patience and support... forgot who said it earlier.... violin? I and many of us also supported every fund raiser... and gosh how much ****gin we got of her from many for doing that

Ray niggles that team scancell science overcame :) ...nothing not nothing can compare to the SCIB1 combo saga lol... though even that looks so much better now :)

One thing is for sure Modify is no SCIB1 combo saga!!!!

We have waited a very very long time...... but if what is happening is true... and well I'm not betting against it... something very special is going to be happening here ...so few patients dosed on the Modify trial so far especially therapeutically dosed.... patients that have been through all current treatments to no avail now experience what we all hoped they would

:)

This was the stated plan when the MaBs came in-house - commercialise the MaBs early in order to fund the trials to get the data to get the maximum value for those products (especially moditope) and that is what is happening ...next up a Covidty partner as stated? I reckon if the data is compelling we can expect that to move forwards and indeed could attract a whole ImmunoBody platform partnership deal....

The Big total buy is ever possible but that is not the current stated plan .... be fascinating to know what the conversations around moditope now are with outside interested parties whom we have been told have been keeping a keen eye on since its discovery announcement all the way back when C7 was in shorts

I suppose one positive is GenMab does not seem short of funds available to push the MaB through and into trial and possibly beyond which always helps... so then it is up to who makes the decisions and how they see this MaB as part of their pipeline priorities

With deal BOD changes, results and now this promising Modify RNS you would expect we would have had a great Lindy 'interview' seeing as, unlike CH her performances do not sink SP :) ...to get to see how she tells the very early promising data from modi 1 would certainly be telling I reckon....

Well done mate on the successful trades and having that core holding thats the way to do it .... you can get your 6p per share gains plus win the £8 lotto :)))

No Lindy media remains the mystery of this fruitful period...something else coming?? Anyways not too long to AGM and compared to past ones I reckon this one will have a far more relaxed atmosphere even the whole SCIB1 combo saga has lost its Albatros effect despite the eternal timelines ...SCIB2 -vanished?.....

SP well not really a great deal has been made from the modi 1 RNS but it could be what bags the greatest deal of all... time!